Medizen Humancare Co (XKRX:236340) Debt-to-Equity : -0.08 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Medizen Humancare Co Debt-to-Equity?

Medizen Humancare Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩667 Mil. Medizen Humancare Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩189 Mil. Medizen Humancare Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩-10,280 Mil. Medizen Humancare Co's debt to equity for the quarter that ended in Dec. 2023 was -0.08.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Medizen Humancare Co's Debt-to-Equity or its related term are showing as below:

XKRX:236340' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.87 Med: -0.34 Max: -0.08
Current: -0.08

During the past 7 years, the highest Debt-to-Equity Ratio of Medizen Humancare Co was -0.08. The lowest was -0.87. And the median was -0.34.

XKRX:236340's Debt-to-Equity is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 0.23 vs XKRX:236340: -0.08

Medizen Humancare Co Debt-to-Equity Historical Data

The historical data trend for Medizen Humancare Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medizen Humancare Co Debt-to-Equity Chart

Medizen Humancare Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-0.28

-0.34

-0.36

-0.19

-0.08

Medizen Humancare Co Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Debt-to-Equity	Get a 7-Day Free Trial			-0.28	-0.34	-0.36	-0.19	-0.08

Competitive Comparison of Medizen Humancare Co's Debt-to-Equity

For the Diagnostics & Research subindustry, Medizen Humancare Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medizen Humancare Co's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medizen Humancare Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Medizen Humancare Co's Debt-to-Equity falls into.

Medizen Humancare Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Medizen Humancare Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(667.441	+	189.411)	/	-10280.274
	=	-0.08

Medizen Humancare Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(667.441	+	189.411)	/	-10280.274
	=	-0.08

Medizen Humancare Co (XKRX:236340) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Medizen Humancare Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Medizen Humancare Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medizen Humancare Co (XKRX:236340) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medizen Humancare Inc Co Ltd (XKRX:236340) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Republic of Korea 223, Teheran-ro, Gangnam-gu, Seoul, KOR

Website

http://www.medizencare.com

Medizen Humancare Inc Co Ltd is a R&D company providing genomics involving acquisition of disease specific genome contents, identification of new drug candidate genes and development of new preventive measures.

Medizen Humancare Co (XKRX:236340) Headlines

No Headlines